Atlantic International Past Earnings Performance
Past criteria checks 0/6
Atlantic International's earnings have been declining at an average annual rate of -247.7%, while the Life Sciences industry saw earnings growing at 16.8% annually. Revenues have been declining at an average rate of 6.6% per year.
Key information
-247.7%
Earnings growth rate
n/a
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | -6.6% |
| Return on equity | n/a |
| Net Margin | -4.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Atlantic International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 404 | -18 | 46 | 0 |
| 31 Dec 23 | 401 | -15 | 45 | 0 |
| 30 Sep 23 | 407 | -11 | 40 | 0 |
| 30 Jun 23 | 417 | -8 | 41 | 0 |
| 31 Mar 23 | 433 | -5 | 42 | 0 |
| 31 Dec 22 | 442 | -3 | 42 | 0 |
| 31 Dec 21 | 425 | -41 | 42 | 0 |
Quality Earnings: ATLN is currently unprofitable.
Growing Profit Margin: ATLN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ATLN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ATLN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ATLN is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-6.5%).
Return on Equity
High ROE: ATLN's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.